Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP814579.RAbLRCJPThJTCDNCpJYp79uIWWBXZd6kXH_2C7_qHiFy0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP814579.RAbLRCJPThJTCDNCpJYp79uIWWBXZd6kXH_2C7_qHiFy0130_assertion type Assertion NP814579.RAbLRCJPThJTCDNCpJYp79uIWWBXZd6kXH_2C7_qHiFy0130_head.
- NP814579.RAbLRCJPThJTCDNCpJYp79uIWWBXZd6kXH_2C7_qHiFy0130_assertion description "[After adjusting for potential confounders, as well as for other GST gene variants, lung adduct levels significantly increased by 150.3% [95% confidence interval (95% CI), 35.4-362.6%] for the GSTM1 null and by 73.9% (95% CI, -3.2% to 212.4%) for the NAT2 slow acetylator genotype, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814579.RAbLRCJPThJTCDNCpJYp79uIWWBXZd6kXH_2C7_qHiFy0130_provenance.
- NP814579.RAbLRCJPThJTCDNCpJYp79uIWWBXZd6kXH_2C7_qHiFy0130_assertion evidence source_evidence_literature NP814579.RAbLRCJPThJTCDNCpJYp79uIWWBXZd6kXH_2C7_qHiFy0130_provenance.
- NP814579.RAbLRCJPThJTCDNCpJYp79uIWWBXZd6kXH_2C7_qHiFy0130_assertion SIO_000772 20501762 NP814579.RAbLRCJPThJTCDNCpJYp79uIWWBXZd6kXH_2C7_qHiFy0130_provenance.
- NP814579.RAbLRCJPThJTCDNCpJYp79uIWWBXZd6kXH_2C7_qHiFy0130_assertion wasDerivedFrom befree-2016 NP814579.RAbLRCJPThJTCDNCpJYp79uIWWBXZd6kXH_2C7_qHiFy0130_provenance.
- NP814579.RAbLRCJPThJTCDNCpJYp79uIWWBXZd6kXH_2C7_qHiFy0130_assertion wasGeneratedBy ECO_0000203 NP814579.RAbLRCJPThJTCDNCpJYp79uIWWBXZd6kXH_2C7_qHiFy0130_provenance.